Just five years ago, on May 11, 2016, President Obama signed the Defend Trade Secrets Act (the “DTSA”). This important legislation created a new, federal civil cause of action for trade secret misappropriation. The DTSA came on the heels of the 2011 America Invents Act (the “AIA”)—the most significant ...More
Over the course of the past year, many trial attorneys in state and federal courts have seen cases effectively stayed by COVID-related delays. COVID hampered in-person discovery and caused courts to re-set jury trial dates. Such disruptions in the timelines of cases are not new to patent litigators, however. Even ...More
- NFTs: The Future of Managing Patent Assets?
- There Won’t Always Be a Stark in Delaware
- Significant Current Issues in Patent Litigation: What to Watch in 2022
- How the Shift to a Permanent Remote Workforce Can Impact Venue for Patent Infringement Lawsuits
- What’s Really Going on with Fintiv at the Patent Trial and Appeal Board?
- United States v. Arthrex: Power given to PTAB Patent Judges “Incompatible” with their Appointment
- Anticipating President Biden’s Intellectual Property Policy in an Historical Context
- Patent and Trade Secret Protection of Inventions: 5 Things to Remember on the 5th Anniversary of the Defend Trade Secrets Act
- To Stay or Not to Stay: the Impact of IPRs on Patent Litigation
- Patent Litigation Considerations for the Internet of Medical Things (IoMT) COVID-19 Boom